Nabiha Saklayen
CEO and co-founder of Cellino
Nabiha Saklayen, CEO and co-founder of Cellino, a company developing AI-powered biomanufacturing systems for personalized cell therapies.
Saklayen’s goal is to revolutionize the treatment landscape for diseases such as Parkinson's, heart disease, and diabetes by making personalized cell therapies more accessible and affordable.
Background and Early Life: Born in Riyadh to Bangladeshi parents, Saklayen's childhood was truly international, with time spent in Bangladesh, Germany, and Sri Lanka.
Education and Achievements: Saklayen completed her BS at Emory University and her Ph.D. in Physics from Harvard University. Her achievements include:
► MIT Tech Review's 35 Innovators Under 35 list for her patented inventions in cellular laser editing
► 30 Under 30 Healthcare list
► Inaugural Tory Burch Foundation Fellow in Genomics at the Innovative Genomics Institute, led by Nobel Laureate Dr. Jennifer Doudna
In 2017, Saklayen co-founded Cellino Biotech to revolutionize cell therapy.
► The company combines stem cell biology, laser physics, and machine learning to increase production efficiency.
► Cellino has raised $97.2 million from notable investors like Khosla and Bayer and was just awarded a $25 million grant from ARPA-H for stem cell research.
Saklayen's story is incredibly inspiring. 😎 It's amazing to see a woman leading the charge in such a cutting-edge and interdisciplinary field in AI and healthcare.
